Antisynthetase syndrome
Tóm tắt
Từ khóa
Tài liệu tham khảo
Wasicek, 1984, Polymyositis and interstitial lung disease in a patient with anti-Jo1 prototype, Am J M, 76, 538, 10.1016/0002-9343(84)90677-6
Nishikai, 1980, Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system, Arthritis Rheum, 23, 881, 10.1002/art.1780230802
Mathews, 1983, Myositis auto-antibodies inhibits histidyl-tRNA synthetase: a model for auto-immunity, Nature, 83, 304
Marguerie, 1990, Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes, Q J M, 77, 1019, 10.1093/qjmed/77.1.1019
Yoshida, 1983, The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis, Arthritis Rheum, 26, 604, 10.1002/art.1780260505
Vazquez-Abad, 1996, Sensitivityand specificity of anti-Jo-1 antibodies in autoimmune diseases with myositis, Arthritis Rheum, 39, 292, 10.1002/art.1780390218
Love, 1991, A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups, Medicine (Baltimore), 70, 360, 10.1097/00005792-199111000-00002
Reichlin, 1984, Multiplicity of antibodies in myositis sera, Arthritis Rheum, 27, 1150, 10.1002/art.1780271011
Hirakata, 1992, Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease, Arthritis Rheum, 35, 449, 10.1002/art.1780350415
Kaminski, 2000, Autoantibody testing in neuromuscular disorders, part II: neuromuscular junction, hyperexcitability, and muscle disorders, J Clin Neuromusc Dis, 2, 96, 10.1097/00131402-200012000-00007
Kajihara, 2000, Myositis and interstitial lung disease associated with autoantibody to a transfer RNA-related protein Wa, J Rheumatol, 27, 2707
Brouwer, 2001, Autoantibody profiles in the sera of European patients with myositis, Ann Rheum Dis, 60, 116, 10.1136/ard.60.2.116
Ascherman, 2001, Characterization of Jo1 specific T cell proliferative responses in polymyositis, Arthritis Rheum, S 263, 1262
Bowles, 1987, Dermatomyositis, polymyositis, and Coxsackie-B-virus infection, Lancet, 1, 1004, 10.1016/S0140-6736(87)92271-9
Miller, 1991, Humoral immunity and immunogenetics in the idiopathic inflammatory myopathies, Curr Opin Rheumatol, 3, 902, 10.1097/00002281-199112000-00002
Plotz, 1983, Autoantibodies are anti-idiotype antibodies to antiviral antibodies, Lancet, 2, 824, 10.1016/S0140-6736(83)90740-7
Cherin, 1996, Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis, J Rheumatol, 23, 1135
Benveniste, 2001, Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients, J Immunol, 167, 3521, 10.4049/jimmunol.167.6.3521
Hirakata, 2000, Interstitial lung disease in polymyositis and dermatomyositis, Curr Opin Rheumatol, 12, 501, 10.1097/00002281-200011000-00005
Ohosone, 1998, Spectrum and clinical significance of autoantibodies against transfer RNA, Arthritis Rheum, 41, 1625, 10.1002/1529-0131(199809)41:9<1625::AID-ART13>3.0.CO;2-D
Bernstein, 1984, Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease, Br Med J (Clin Res Ed), 289, 151, 10.1136/bmj.289.6438.151
Bunn, 1986, Autoantibodies against alanyl-tRNA synthetase and tRNAAla coexist and are associated with myositis, J Exp M, 163, 1281, 10.1084/jem.163.5.1281
Targoff, 1988, Antibody to threonyl-transfer RNA synthetase in myositis sera, Arthritis Rheum, 31, 515, 10.1002/art.1780310408
Hausmanowa-Petrusewicz, 1997, Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies, Arthritis Rheum, 40, 1257, 10.1002/1529-0131(199707)40:7<1257::AID-ART10>3.0.CO;2-R
Oddis, 1990, A subluxing arthropathy associated with the anti-Jo-1 antibody in polymyositis/dermatomyositis, Arthritis Rheum, 33, 1640, 10.1002/art.1780331106
Hochberg, 1984, Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease, J Rheumatol, 11, 663
Mathews, 1984, Anti threonyl-tRNA synthetase, a second myositis related auto-antibody, J Exp M, 160, 420, 10.1084/jem.160.2.420
Targoff, 1992, Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease, Arthritis Rheum, 35, 821, 10.1002/art.1780350718
Reichlin, 1984, Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes, J Clin Immunol, 4, 40, 10.1007/BF00915286
Dalakas, 1991, Polymyositis, dermatomyositis, and inclusion-body myositis, N Engl J M, 325, 1487, 10.1056/NEJM199111213252107
Bohan, 1975, Polymyositis and dermatomyositis (second of two parts), N Engl J M, 292, 403, 10.1056/NEJM197502202920807
Bohan, 1975, Polymyositis and dermatomyositis (first of two parts), N Engl J M, 292, 344, 10.1056/NEJM197502132920706
Mozaffar, 2000, Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres, J Neurol Neurosurg Psychiatry, 68, 472, 10.1136/jnnp.68.4.472
Friedman, 1996, Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis, Semin Arthritis Rheum, 26, 459, 10.1016/S0049-0172(96)80026-6
Queiro-Silva, 2001, Periarticular calcinosis associated with anti-Jo-1 antibodies sine myositis. Expanding the clinical spectrum of the antisynthetase syndrome, J Rheumatol, 28, 1401
Jeffrey, 1985, Lung inflammation in scleroderma: clinical, radiographic, physiologic and cytopathological features, J Rheumatol, 12, 957
Flammang d'Ortho, 1991, Atteintes pulmonaires interstitielles des polymyosites et dermatomyosites. À propos de 3 observations. Revue de la littérature, Rev Pneumol Clin, 47, 29
Schwarz, 1976, Interstitial lung disease in polymyositis and dermatomyositis: analysis of six cases and review of the literature, Medicine (Baltimore), 55, 89, 10.1097/00005792-197601000-00005
Turner-Warwick, 1987, The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis, Am Rev Respir Dis, 135, 26
Miller, 1990, Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity, Am Rev Respir Dis, 141, 301, 10.1164/ajrccm/141.2.301
Chatte, 1992, Pneumopathie interstitielle fibrosante et dermatomyosite. Histologie pulmonaire et pronostic, Rev Mal Respir, 9, 634
Hirakata, 1996, Autoantibodies to glycyl-transfer RNA synthetase in myositis. Association with dermatomyositis and immunologic heterogeneity, Arthritis Rheum, 39, 146, 10.1002/art.1780390119
Fergusson, 1983, Dermatomyositis and rapidly progressive fibrosing alveolitis, Thorax, 38, 71, 10.1136/thx.38.1.71
Job-Deslandre, 1982, L'atteinte pulmonaire au cours de la dermatopolymyosite. Étude restrospective de 4 observations, Nouv Presse M, 11, 3317
Takizawa, 1987, Interstitial lung disease in dermatomyositis: clinicopathological study, J Rheumatol, 14, 102
Ito, 1999, Clinico-laboratory characteristics of patients with dermatomyositis accompanied by rapidly progressive interstitial lung disease, Clin Rheumatol, 18, 462, 10.1007/s100670050139
Sauty, 1997, Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies, Eur Respir J, 10, 2907, 10.1183/09031936.97.10122907
Marie, 1999, Atteinte pulmonaire au cours de la sclérodermie systémique. Partie I. Pneumopathie interstitielle chronique fibrosante, Rev Med Interne, 20, 1004, 10.1016/S0248-8663(00)87081-2
Costabel, 2001, International consensus statement on idiopathic pulmonary fibrosis, Eur Respir J, 17, 163, 10.1183/09031936.01.17201630
Mino, 1997, Pulmonary involvement in polymyositis and dermatomyositis: sequential evaluation with CT, Am J Roentgenol, 169, 83, 10.2214/ajr.169.1.9207505
Akira, 1999, Interstitial lung disease in association with polymyositis-dermatomyositis: long-term follow-up CT evaluation in seven patients, Radiology, 210, 333, 10.1148/radiology.210.2.r99ja15333
Lohr, 1993, Interstitial alveolitis as early manifestation of anti-Jo-1 positive polymyositis, Rheumatology, 52, 307
Wallaert, 1986, Atteinte pulmonaire des dermatomyosites. Intérêt du lavage broncho-alvéolaire, Presse M, 15, 1247
Tubery, 1997, Évolution des pneumopathies interstitielles associées aux myopathies inflammatoires. À propos de 5 observations, Ann Med Interne, 148, 2
Lakhanpal, 1987, Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases, Ann Rheum Dis, 46, 23, 10.1136/ard.46.1.23
Tazelaar, 1990, Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings, Am Rev Respir Dis, 141, 727, 10.1164/ajrccm/141.3.727
Bunch, 1976, Deforming arthritis of the hands in polymyositis, Arthritis Rheum, 19, 243, 10.1002/art.1780190217
Cohen, 1987, Finger joint calcinosis followed by osteolysis in a patient with multisystem connective tissue disease and anti-Jo-1 antibody, J Rheumatol, 14, 605
Kazmers, 1988, Polymyositis associated apatite arthritis, J Rheumatol, 15, 1019
Alarcon-Segovia, 1979, Mutilans-like arthropathy in mixed connective tissue disease, Arthritis Rheum, 22, 1013, 10.1002/art.1780220910
Citera, 1996, Apatite deposition in polymyositis subluxing arthropathy, J Rheumatol, 23, 551
Greenway, 1981, Deforming arthritis of the hands: an unusual manifestation of polymyositis, AJR Am J Roentgenol, 136, 611, 10.2214/ajr.136.3.611
Lifermann, 1992, Arthropathie déformante associée à la présence d'un anticorps anti-Jo1 au cours de la polymyosite. Un nouveau cas, Presse M, 21, 1423
Schmidt, 2000, Clinical and serological aspects of patients with anti-Jo-1 antibodies—an evolving spectrum of disease manifestations, Clin Rheumatol, 19, 371, 10.1007/s100670070030
Leteurtre, 1994, Manifestations vasculaires des dermatomyosites et polymyosites. Aspects cliniques, capillaroscopiques et histologiques, Rev Med Interne, 15, 800, 10.1016/S0248-8663(05)82836-X
Meyer, 1987, Principaux anticorps antinucléaires et anticytoplasme au cours des polymyosites et des dermatomyosites. Étude de 42 observations, Presse M, 16, 155
Targoff, 1993, Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase, J Clin Invest, 91, 2556, 10.1172/JCI116493
Hirakata, 1999, Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease, J Immunol, 162, 2315, 10.4049/jimmunol.162.4.2315
Targoff, 1987, Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity, J Immunol, 138, 2874, 10.4049/jimmunol.138.9.2874
Arnett, 1981, The Jo-1 antibody system in myositis: relationships to clinical features and HLA, J Rheumatol, 8, 925
Godeau, 1980, Évolution et pronostic à long terme de 50 cas de dermatomyosites et polymyosites, Rev Med Interne, 1, 29, 10.1016/S0248-8663(80)80006-3
Turner-Warwick, 1980, Cryptogenic fibrosing alveolitis: clinical features and their influence on survival, Thorax, 35, 171, 10.1136/thx.35.3.171
Arsura, 1988, Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis, Semin Arthritis Rheum, 18, 29, 10.1016/0049-0172(88)90032-7
Qushmaq, 2000, Cyclosporine A in the treatment of refractory adult polymyositis/dermatomyositis: population based experience in 6 patients and literature review, J Rheumatol, 27, 2855
al-Janadi, 1989, Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis, J Rheumatol, 16, 1592
Cherin, 1991, Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients, Am J M, 91, 162, 10.1016/0002-9343(91)90009-M
Cherin, 1999, Les immunoglobulines intraveineuses dans les polymyosites et les dermatomyosites, Rev Med Interne, 20, 436s, 10.1016/S0248-8663(00)88675-0
Bunch, 1981, Prednisone and azathioprine for polymyositis: long-term followup, Arthritis Rheum, 24, 45, 10.1002/art.1780240107
Oddis, 1999, Tacrolimus in refractory polymyositis with interstitial lung disease, Lancet, 353, 1762, 10.1016/S0140-6736(99)01927-3
Tellus, 1995, Effective treatment of anti Jo-1 antibody-positive polymyositis with cyclosporine, Br J Rheumatol, 34, 1187, 10.1093/rheumatology/34.12.1187
Joffe, 1993, Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy, Am J M, 94, 379, 10.1016/0002-9343(93)90148-I